KEGG: ljo:LJ_0003
STRING: 257314.LJ0003
RecF in L. johnsonii is part of the RecF pathway of DNA recombination and repair, which plays a critical role in maintaining genomic integrity. Based on studies of homologous proteins in other bacteria like E. coli, RecF is primarily involved in the resumption of replication at disrupted DNA replication forks and participates in repairing DNA double-strand breaks .
The protein functions in concert with other members of the RecF pathway, particularly RecO and RecR. Together, these proteins enable the reassembly of replication machinery at sites where replication has been disrupted. This function is particularly important for bacterial survival under conditions of DNA damage or stress .
The recF gene in L. johnsonii is part of the core genome shared among different L. johnsonii strains. Based on genomic analysis of multiple L. johnsonii strains, including strain ZLJ010, NCC533, and others, recF is maintained as part of the essential genomic infrastructure .
Genomic studies reveal that L. johnsonii has a genome size of approximately 1.8-2.0 Mb, with recF being part of the approximately 1,300 gene clusters that constitute the core genome across different L. johnsonii strains . Unlike some strain-specific genes that may be associated with prophages or mobile genetic elements, recF is conserved, reflecting its essential function in DNA metabolism.
Several genetic modification approaches have been successfully applied to L. johnsonii, with varying efficiencies:
For recF modification specifically, the Cre/loxP system has shown excellent results in Lactobacilli, allowing for precise modifications with high efficiency. This approach is particularly valuable for creating functional modifications to the RecF protein while minimizing unwanted genomic alterations .
When expressing recombinant proteins on the cell surface (as might be desired for certain RecF applications), approaches using cell wall anchored proteins like PrtB from Lactobacillus delbrueckii have proven effective. This method has been successfully used to express fusion proteins on the surface of L. johnsonii .
The choice of expression vector depends on the specific research objectives. For therapeutic applications, plasmid stability and food-grade selection markers are essential considerations:
pPG612-based vectors: Successfully used for expressing bovine GM-CSF in L. johnsonii, showing good stability over 40 generations . This vector system is particularly valuable for therapeutic applications.
Food-grade vector systems: For applications where antibiotic resistance markers are undesirable, vectors using the conditionally lethal gene pheS* as a negative selection marker combined with temperature-sensitive replicons (such as pGhost9) have shown excellent results in Lactobacillus species .
For RecF protein expression specifically, vector systems should incorporate:
Strong, preferably inducible promoters
A secretion signal if extracellular or surface expression is desired
Appropriate tag sequences for purification or detection
Stable replicons for maintenance in L. johnsonii
The design should consider the relatively high A-T content of the L. johnsonii genome (~65-70%) for optimal codon usage .
Verifying RecF functionality requires a multi-faceted approach:
UV sensitivity assay: RecF-deficient bacteria show hypersensitivity to UV radiation. Complementation with functional recombinant RecF should restore normal UV resistance . This can be measured by comparing survival rates of wild-type, RecF-deficient, and complemented strains after UV exposure.
DNA replication fork recovery assay: Since RecF is essential for the resumption of replication at stalled forks, DNA fiber analysis or pulse-field gel electrophoresis can be used to monitor replication restart after induced replication fork stalling (e.g., with hydroxyurea treatment) .
In vitro reconstitution assay: A biochemical approach involving purified RecF, RecO, RecR, RecA, RecQ, RecJ, and SSB proteins to reconstitute the DNA repair process in vitro. Successful joint molecule formation between linear dsDNA and supercoiled DNA indicates functional RecF .
Genetic complementation studies: Introduction of recombinant RecF into RecF-deficient strains should complement phenotypic defects if the protein is functional.
Protein-protein interaction studies: Co-immunoprecipitation or bacterial two-hybrid assays to verify interactions between recombinant RecF and known partners like RecO and RecR.
The recommended approach is to employ multiple methods, as each provides different insights into RecF functionality.
Modifications to the RecF protein can lead to several observable phenotypic changes:
Altered DNA damage response: Strains with defective RecF show increased sensitivity to DNA-damaging agents, particularly UV radiation . Conversely, enhanced RecF function might confer greater resistance.
Changes in mutation rates: RecF is involved in maintaining genomic stability; modifications may alter spontaneous mutation frequencies.
Growth characteristics: Significant RecF modifications may affect growth rates, particularly under stressful conditions. This can be measured through growth curve analysis under various conditions.
Prophage induction: In L. johnsonii strains containing prophages (like the NCC533 strain with prophages Lj928 and Lj965), RecF function may influence prophage stability and induction rates .
Recombination efficiency: Changes in homologous recombination rates may be observed, which can be measured using appropriate recombination reporter systems.
When designing experiments to assess these phenotypes, it is essential to include appropriate controls, including wild-type strains and complete RecF deletion mutants for comparison.
RecF functions within a network of protein interactions comprising the RecF pathway. In E. coli, the RecFOR complex (RecF, RecO, RecR) facilitates RecA loading onto SSB-coated ssDNA at processed ssDNA-dsDNA junctions . In L. johnsonii, similar interactions are expected but remain less characterized.
Methods to study these interactions include:
Bacterial two-hybrid assays: To identify direct protein-protein interactions between RecF and other repair proteins.
Co-immunoprecipitation followed by mass spectrometry: To identify the interactome of RecF in vivo.
Fluorescence microscopy using fluorescently tagged proteins: To visualize co-localization of RecF with other repair proteins during DNA damage response.
In vitro reconstitution assays: Using purified components to reconstruct the DNA repair pathway and study the biochemical requirements for each step.
ChIP-seq analysis: To map genome-wide binding sites of RecF and associated proteins during normal growth and after DNA damage.
Recent studies using reconstituted systems have shown that RecF, RecO, and RecR have distinct but complementary roles in facilitating RecA loading onto DNA. RecO and RecR mediate exchange of RecA for SSB, while RecF acts with RecO and RecR to load RecA at ssDNA-dsDNA junctions . Similar approaches could be applied specifically to L. johnsonii RecF to elucidate potential species-specific interaction patterns.
L. johnsonii has shown significant promise as a delivery vehicle for therapeutic molecules, including vaccines and immunomodulatory proteins. Recombinant L. johnsonii expressing modified RecF could have several therapeutic applications:
Enhanced DNA damage resistance: Modified RecF that improves DNA repair efficiency could enhance L. johnsonii survival in harsh environments like the gastrointestinal tract, improving probiotic efficacy.
Vector stability: Optimized RecF function could enhance the genetic stability of therapeutic vectors in L. johnsonii, ensuring consistent expression of therapeutic proteins over time.
Adjuvant effects: RecF or RecF-derived peptides could potentially serve as immune-stimulating adjuvants when co-expressed with vaccine antigens, enhancing immune responses.
Research by Scheppler et al. demonstrated that L. johnsonii can be effectively used as a mucosal vaccine delivery vehicle, partly due to its ability to survive gastric conditions . By engineering RecF to enhance DNA damage resistance, the survival and efficacy of such vaccine vehicles could potentially be improved.
While RecF is functionally conserved across bacterial species, important structural and regulatory differences exist:
| Species | RecF Size | Key Structural Features | Regulatory Mechanisms | Associated Phenotypes |
|---|---|---|---|---|
| L. johnsonii | ~360-370 aa | Conserved Walker A/B motifs | Not fully characterized | Part of core genome; likely essential |
| E. coli | 357 aa | ATP-binding domain; DNA-binding domain | SOS-inducible | UV sensitivity when deficient |
| B. subtilis | 368 aa | Similar domain organization to E. coli | Regulated by RecX | Competence defects when mutated |
One key research question is whether RecF in L. johnsonii has adapted to the specific genomic architecture and repair needs of this organism, which contains multiple prophage regions and other mobile genetic elements .
Optimizing culture conditions is critical for efficient recombinant protein production in L. johnsonii. Based on studies with various Lactobacillus strains, the following conditions have shown positive results:
For specific RecF expression, additional considerations include:
Protein solubility: RecF is typically soluble when expressed at moderate levels. Overexpression may lead to inclusion body formation.
Induction strategy: For temperature-sensitive or chemical-inducible promoters, gradual induction may yield better results than sudden induction.
Growth media supplements: Addition of specific fatty acids like erucic acid may modify L. johnsonii membrane composition, potentially affecting protein expression and activity .
A sequential quadratic programming approach, as described by Lee et al., can be used to optimize multiple parameters simultaneously for maximum recombinant protein production .
When studying RecF function in L. johnsonii, several critical experimental design factors must be considered:
Genetic background selection:
Control constructs:
Include wild-type RecF expression as positive control
Use catalytically inactive RecF mutants (e.g., Walker A motif mutations) as negative controls
Consider complementation controls with RecF from well-characterized species like E. coli
DNA damage induction:
Use appropriate DNA damaging agents at optimized concentrations
UV irradiation: 10-50 J/m² (calibrated for Lactobacillus sensitivity)
Chemical agents: mitomycin C (0.1-1 μg/ml), methyl methanesulfonate (0.01-0.1%)
Phenotypic assays:
Growth curves under normal and stress conditions
Survival assays following DNA damage
Microscopy to observe cell morphology and nucleoid structure
Recombination frequency measurements
Protein expression verification:
Western blotting with specific antibodies
Activity assays (e.g., ATP hydrolysis for RecF)
Protein localization studies
Statistical considerations:
Minimum of three biological replicates
Appropriate statistical tests based on data distribution
Power analysis to determine sample size
When designing mutations or variants of RecF, conserved functional domains should be identified through multiple sequence alignment with well-characterized RecF proteins from model organisms.
Researchers often encounter several challenges when developing recombinant L. johnsonii strains:
Low transformation efficiency:
Plasmid instability:
Heterologous protein expression issues:
Problem: Poor expression levels or inactive protein.
Solution: Codon optimization for L. johnsonii (high A+T content); use L. johnsonii-derived promoters and signal peptides; consider fusion with well-expressed L. johnsonii proteins.
Unwanted recombination events:
Problem: Homologous recombination between repeated sequences in expression constructs.
Solution: Minimize sequence repetition in constructs; use recombination-deficient host strains for plasmid propagation; verify construct integrity after transformation.
Selective marker limitations:
Phage contamination:
Problem: Prophage induction or external phage infection.
Solution: Choose L. johnsonii strains with characterized prophage content; implement phage monitoring; consider CRISPR-based approaches for phage resistance.
For RecF-specific expression challenges, careful attention to protein folding and potential toxicity of overexpressed DNA-binding proteins is essential. Expression as fusion proteins with solubility-enhancing partners or under tightly controlled inducible promoters may mitigate these issues.
Inconsistent results are a common challenge in research with recombinant proteins in non-model organisms like L. johnsonii. Several approaches can help address this issue:
Standardize growth and induction conditions:
Implement rigorous quality control:
Verify plasmid sequence before each experiment
Confirm protein expression by Western blot
Check for potential mutations in expression strains
Implement routine phenotypic tests to confirm strain identity
Control for genetic drift:
Make working stocks from master cultures
Limit passage number before returning to original stocks
Store multiple glycerol stocks at -80°C
Address physiological variability:
Pre-adapt cultures to experimental conditions
Use biological triplicates from independent colonies
Control for growth phase effects by synchronizing cultures
Optimize biochemical assays:
Determine linear range for each assay
Include internal controls in each experiment
Validate key results with orthogonal methods
Systematic troubleshooting approach:
Isolate variables one at a time
Document all experimental conditions meticulously
Implement positive and negative controls for each assay
For RecF specifically, its function in DNA metabolism means that experimental conditions causing DNA stress (suboptimal media, contaminating DNA-damaging compounds, excessive aeration) may significantly impact results by triggering native stress responses that interact with recombinant RecF function.
Emerging technologies offer new opportunities for understanding RecF function in L. johnsonii:
CRISPR interference (CRISPRi) for tunable gene repression:
Single-molecule techniques:
Single-molecule fluorescence resonance energy transfer (smFRET) to observe RecF-DNA interactions
DNA curtain assays to visualize RecF activity on DNA substrates in real-time
Optical tweezers to study mechanical aspects of RecF-mediated DNA transactions
In situ structural studies:
Cryo-electron tomography to visualize RecF in cellular context
Proximity labeling approaches (BioID, APEX) to map RecF interaction network in vivo
In-cell NMR to study RecF conformational changes during DNA damage response
Systems biology approaches:
Multi-omics integration (transcriptomics, proteomics, metabolomics) to understand global effects of RecF modification
Network analysis to position RecF within the broader DNA damage response network
Mathematical modeling of RecF pathway dynamics
Synthetic biology tools:
Split protein complementation assays for RecF to study domain interactions
Optogenetic control of RecF expression or activity
Engineering of orthogonal RecF variants with novel functionalities
These approaches, combined with the genetic engineering tools specifically developed for Lactobacillus species , offer powerful ways to advance our understanding of RecF biology in L. johnsonii.
Engineered RecF variants could significantly enhance L. johnsonii applications through several mechanisms:
Stress resistance enhancement:
RecF variants with enhanced DNA repair capacity could improve L. johnsonii survival during:
Gastrointestinal transit (acid, bile, oxidative stress)
Manufacturing processes (lyophilization, storage)
Therapeutic delivery to inflammatory environments
This could extend shelf life and in vivo persistence of probiotic preparations
Genetic stabilization of therapeutic constructs:
Optimized RecF could reduce mutation rates in expression cassettes
Enhanced homologous recombination capacity could facilitate stable chromosomal integration of therapeutic genes
Reduced prophage activation through improved DNA maintenance
Controlled biocontainment:
Engineered conditional RecF variants could enable environmental containment strategies
Inducible RecF inactivation could trigger programmed cell death under specific conditions
This addresses biosafety concerns with engineered probiotics
Adjuvant properties:
RecF-derived peptides could potentially act as immune-stimulating molecules
Co-expression with antigens might enhance immunological memory
This could improve L. johnsonii-based vaccine efficacy
Delivery system optimization:
RecF engineering could enhance the efficiency of DNA delivery to mammalian cells
Modified DNA transfer mechanisms might improve therapeutic nucleic acid delivery
This could create new applications in gene therapy